No abstract available
MeSH terms
-
Antiviral Agents / economics*
-
Cost-Benefit Analysis
-
Hepatitis C / drug therapy*
-
Hepatitis C / economics*
-
Humans
-
Insurance, Health, Reimbursement / economics
-
Netherlands
-
Practice Guidelines as Topic
-
Quality-Adjusted Life Years